Antiparasitic treatment for severe Plasmodium falciparum malaria;Conduite pratique du traitement antiparasitaire d'une forme grave de paludisme a Plasmodium falciparum

Medecine et Maladies Infectieuses

Volumn 29, Issue SUPPL. 3, 1999, Pages 356-371

  Debord, T ^a   Imbert, P ^a,b   Saissy, J M ^a   Roue R ^a  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b HÔPITAL PRINCIPAL DE DAKAR   (Senegal)

Author keywords

Artemether; Clindamycin; Doxycycline; Plasmodium falciparum; Quinine; Severe malaria

Indexed keywords

ARTEMETHER; CIMETIDINE; DOXYCYCLINE; PHENOBARBITAL; QUINIMAX; QUININE; QUININE FORMATE;

CARDIOTOXICITY; CONFERENCE PAPER; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG MONITORING; FRANCE; HUMAN; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; SCHIZONT; TREATMENT INDICATION;

EID: 0033382285     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(99)80073-0     Document Type: Conference Paper

References (90)

1. Gramiccia G. Notes on the early history of cinchona plantations. Acta Leidensia 1987 ; 55 : 5-13.
2. Jernican JA, Pearson RD. Antiparasitic agents. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. Churchill Livingstone; 1995. p. 458-92.
3. Jacqz-Aigrain E, Bennasr S, Desplanques L, Peralma A, Beaufils F. Les risques d'intoxication grave liés à l'administration intraveineuse de quinine. Arch Pédiatr 1994 ; 1 : 14-9.
4. Le Bras J, Longuet C, Charmot G. Transmission humaine et résistance des plasmodies. Rev Prat 1998 ; 48 : 258-63.
5. Ter Kuile F, White NJ, Holloway P, et al. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitol 1993 ; 76 : 85-95.
6. White NJ. Malaria. In: Cook GC, ed. Manson's Tropical diseases. WB Saunders Company; 1996. p. 1087-164.
7. Basco LK, Ruggeri C, Le Bras J. Molécules antipaludiques. Paris : Masson ; 1994.
8. Bouchaud O, Le Bras J. Paludisme. In : Carbon C, Regnier B, Saimot G, Vilde JL, Yeni P, éd. Médicaments anti-infectieux. Paris : Médecine-Sciences Flammarion ; 1994. p. 337-62.
9. Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet 1996 ; 4 : 263-99.
10. World Health Organisation, Division of Control of Tropical Diseases. Severe and complicated malaria. Second edition. Trans R Soc Trop Med Hyg 1990 ; 84 Suppl 2 : 1-65.
11. White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Bunnag D, Harinasuta T. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 1982 ; 73 : 564-72.
12. White NJ, Chanthavanich P, Krishna S, et al. Quinine disposition kinetics. Br J Clin Pharmacol 1983 ; 16 : 399-403.
13. Davis TME, White NJ, Looareesuwan S, Silamut K, Warrell DA. Quinine pharmacokinetics in cerebral malaria: predicted plasma concentrations after rapid intravenous loading using a two-compartment model. Trans R Soc Trop Med Hyg 1988 ; 82 : 542-7.
14. White NJ. Antimalarial pharmacokinetics and treatment regimens. Br J Clin Pharmacol 1992 ; 34 : 1-10.
15. White NJ. Controversies in the management of severe falciparum malaria. Baillière's Clin Infect Dis 1995 ; 2 : 309-30.
16. Silamut K, White NJ, Looareesuwan S, et al. Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg 1985 ; 34 : 681-6.
17. Karbwang J, Thanavibul A, Molunto P, Na Bangchang K. The pharmacokinetics of quinine in patients with hepatitis. Br J Clin Pharmacol 1993 ; 35 : 444-6.
18. Auprayoon P, Sukontason K, Na-Bangchang K, et al. Pharmacokinetics of quinine in chronic liver disease. Br J Clin Pharmacol 1995 ; 40 : 494-7.
19. Charmot G. Protocoles thérapeutiques. In : Danis M, Mouchet J, éd. Paludisme. Paris : Ellipses ; 1991. p. 168-78.
20. Sukontason K, Karbwang J, Rimchala W, Tin T, Na-Bangchang K, Banmairuroi V, et al. Plasma quinine concentrations in falciparum malaria with acute renal failure. Trop Med Int Health 1996 ; 1: 236-42.
21. Davies JG, Greenwood EF, Kingswood JC, et al. Quinine clearance in continuous venovenous hemofiltration. Ann Pharmacother 1996 ; 30 : 487-90.
22. Treluyer JM, Roux A, Mugnier C, et al. Metabolism of quinine in children with global malnutrition. Pediatr Res 1996 ; 190 : 558-63.
23. Phillips RE, Looareesuwan S, White NJ, et al. Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria. Br J Clin Pharmacol 1986 ; 21 : 677-83.
24. Martindale. The extra pharmacopeia. In: Reynolds JEF, ed. Royal Pharmaceutical Society; 1996.
25. Savel J, Le Bras J. Antiparasitaires. Encycl Méd Chir (Elsevier, Paris). Maladies infectieuses, 8-006-G-10. 1998 : 20 p.
26. Martins ES, Rogalski K, Black JN. Quinine may trigger torsades de pointes during astemizole therapy. PACE 1997 ; 20 : 2024-5.
27. Brandts CH, Ndjave M, Graninger W, et al. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997 ; 350 : 704-9.
28. Powell RD, McNamara JV. Quinine: side-effects and plasma levels. Proceedings of the Helminthological Society of Washington 1972 ; 39 : 331-8.
29. Tange RA, Dreschler WA, Claessen FAP, et al. Ototoxic reactions of quinine in healthy persons and patients with Plasmodium falciparum infection. Auris Nasus Larynx 1997 ; 24 : 131-6.
30. Roche RJ, Silamut K, Pukrittayakamee S, et al. Quinine induces reversible high-tone hearing loss. Br J Clin Pharmacol 1990 ; 29 : 780-2.
31. L'Estrange Orme. Side effects of quinine and derivatives. Acta Leidensia 1987 ; 55 : 77-86.
32. Boland ME, Brennand Roper SM, Henry JA. Complications of quinine poisoning. Lancet 1985 ; i : 384-5.
33. Bateman DN, Blain PG, Woodhouse KW, Rawlins MD, Dyson EH, Heyworth R, et al. Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Quarterly J Med 1985 ; 54, 214 : 125-31.
34. Waddell K. Blindness from quinine as an antimalarial. Trans R Soc Trop Med Hyg 1996 ; 90 : 331-2.
35. Boele Van Hensbroek M, Kwiatkowski D, Van den Berg B, et al. Quinine pharmacokinetics in young children with severe malaria. Am J Trop Med Hyg 1996 ; 54 : 237-42.
36. Bodenhamer JE, Smilkstein MJ. Delayed cardiotoxicity following quinine overdose: a case report. J Emerg Med 1993 ; 11 : 279-85.
37. Bonington A, Davidson R, Winstanley PA, Pasvol G. Fatal quinine cardiotoxicity in the treatment of falciparum malaria. Trans R Soc Trop Med Hyg 1996 ; 90 : 305-7.
38. Winstanley PA, Newton C, Watkins WM, Mberu E, Warn P, Mwangi I. et al. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentrations. Trans R Soc Trop Med Hyg 1993 ; 87 : 201-6.
39. Hall AP. Quinine infusion for recrudescences of falciparum malaria in Vietnam: a controlled study. Am J Trop Med Hyg 1972 ; 21 : 851-6.
40. Maguire RB, Stroncek DF, Campbell AC. Recurrent pancytopenia, coagulopathy, and renal failure associated with multiple quinine-dependent antibodies. Ann Intern Med 1993 ; 119 : 215-7.
41. McDonald SP, Shanahan EM, Thomas AC, et al. Quinine-induced hemolytic uremic syndrome. Clin Nephrol 1997 ; 47 : 397-400.
42. Pin I, Dor PJ, Vervloet D, et al. Hypersensibilité immédiate à la quinine. Presse Méd 1985 ; 14, 17 : 967-9.
43. Phillips-Howard PA, Wood D. The safety of antimalarial drugs in pregnancy. Drug Saf 1996 ; 3 : 131-45.
44. Nosten F. Artemisinin: large community studies. Trans R Soc Trop Med Hyg 1994 ; 88 Suppl 1 : 45-6.
45. Meshnick SR. The mode of action of malarial endoperoxides. Trans R Soc Trop Med Hyg 1994 ; 88 Suppl 1 : 31-2.
46. White NJ. Clinical pharmacokinetics and pharmacodynamics of artemisinine and derivatives. Trans R Soc Trop Med Hyg 1994 ; 88 Suppl 1 : 41-3.
47. Edwards G. Measurement of artemisinine and its derivatives in biological fluids. Trans R Soc Trop Med Hyg 1994 ; 88 Suppl 1 : 37-9.
48. Ambroise-Thomas P. L'artéméther intramusculaire dans le traitement des paludismes graves : synthèse des résultats actuels. Méd Trop 1997 ; 57 : 289-93.
49. Karbwang J, Na-Bangchang K, Congpuong K, et al. Pharmacokinetics and bio-availability of oral and intramuscular artemether. Eur J Clin Pharmacol 1997 ; 52 : 307-10.
50. Brewer TG, Grate SJ, Peggins JO, et al. Fatal neurotoxicity of arte-ether and artemether. Am J Trop Med Hyg 1994 ; 51 : 251-9.
51. Charmot G, Le Bras J, Coulaud JP. Les antibiotiques dans la chimioprévention et le traitement du paludisme : modes d'action, activités, indications. Ann Institut Pasteur/Actualités 1994 ; 5, 4 : 307-14.
52. Couet W, Laroche R, Floch JJ, et al. Pharmacokinetics of quinine and doxycycline in patients with acute falciparum malaria: a study in Africa. Ther Drug Monitor 1991 ; 13 : 496-501.
53. Kremsner PG. Clindamycin in malaria treatment. J Antimicrob Chemother 1990 ; 25 : 9-14.
54. Winstanley PA. Anti-malarial chemotherapy. Baillière's Clin Infect Dis 1995 ; 2 : 293-308.
55. Bricaire F, Wolff M, Charmot G. Paludisme. Encycl Med Chir (Éditions Techniques, Paris). Thérapeutique, 25064 A10, 11-1990 : 12 p.
56. Clair B, Wolff M, Bedos JP, et al. Importance de l'optimisation de la quinine par voie intraveineuse dans l'accès pernicieux palustre de l'adulte. In : Vachon F, Coulaud JP, Pocidalo JJ, Vilde JL, éd. Chimiothérapie des parasitoses sévères en 1990. Paris : Arnette ; 1990. p. 19-28.
57. Gilles HM. Vade-mecum pour la prise en charge du paludisme grave et compliqué. Genève : Organisation mondiale de la santé ; 1991.
58. White NJ. The treatment of malaria. N Engl J Med 1996 ; 335 : 800-6.
59. Gachot B, Ringwald P. Paludisme pernicieux. Rev Prat 1998 ; 48 : 273-8.
60. Harinasuta J, Karbwang J, Bunnai D. Treatment of malaria. In: Dupont HL, Steffen R, eds. Textbook of travel medicine and health. BC Decker; 1997. p. 114-30.
61. Kain KC, Gadd E, Gushulak B, et al. Errors in treatment recommandations for severe malaria. Lancet 1996 ; 348 : 621.
62. Krogstad DJ. Plasmodium species (malaria). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. Churchill Livingstone; 1995. p. 2415-27.
63. Davis TME, Supanaranond W, Pukrittayakamee S, Karbwang J, Molunto P, Mekthon S, et al. A safe and effective consecutive-infusion regimen for rapide quinine loading in severe falciparum malaria. J Infect Dis 1990 ; 161 : 1305-8.
64. Winstanley PA, Mberu EK, Watkins WM, et al. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. Trans R Soc Trop Med Hyg 1994 ; 88 : 577-80.
65. White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Chanthavanich P, Bunnag D, et al. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg 1983 ; 32 : 1-5.
66. Van der Torn M, Thuma PE, Mabeza GF, et al. Loading dose of quinine in African children with cerebral malaria. Trans R Soc Trop Med Hyg 1998 ; 92 : 325-31.
67. White NJ, Krishna S. Treatment of malaria: some considerations and limitations of the current methods of assessment. Trans R Soc Trop Med Hyg 1989 ; 83 : 767-77.
68. Louis FJ, Fargier JJ, Maubert B. et al. Accès palustre grave de l'adulte au Cameroun : comparaison de deux protocoles thérapeutiques utilisant la quinine par voie parentérale. Ann Soc Belge Med Trop 1992 ; 72 : 179-88.
69. Tombe M, Bhatt KM, Obel AOK. Quinine loading dose in severe falciparum malaria at Kenyatta National Hospital, Kenya. East Afr Med J 1992 ; 69 : 670-4.
70. Mehta SR, Lazar AI, Kasthuri AS. Experience on loading dose-quinine therapy in cerebral malaria. JAPI 1994 ; 42 : 376-8.
71. Pasvol G, Newton CRJC, Winstanley PA, Watkins WM, Peshu NM, Were JBO, et al. Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens. Am J Trop Med Hyg 1991 ; 45 : 702-13.
72. Warrell DA, Looareesuwan S, Warrell MJ, et al. Dexamethasone proves deleterious in cerebral malaria. N Engl J Med 1982 ; 306 : 313-9.
73. Schapira A, Solomon T, Julien M, et al. Comparison of intramuscular and intravenous quinine for the treatment of severe and complicated malaria in children. Trans R Soc Trop Med Hyg 1993 ; 87 : 299-302.
74. Salord F, Allaouchiche B, Gaussorgues P, et al. Severe falciparum malaria (21 cases). Intensive Care Med 1991 ; 17 : 449-54.
75. Hall AP. Controversy - quinine treatment for malaria. Trop Dis Bull 1986 ; 83 : R2-10.
76. White NJ. Optimal regimens of parenteral quinine. Trans R Soc Trop Med Hyg 1995 ; 89 : 462-3.
77. Cegielski JP, Warrell DA. Cerebral malaria. In: Scheld WM, Whitley RJ, Durack DT, eds. Infections of the central nervous system. Lippincott-Raven; 1997. p. 765-84.
78. Warrell DA. Cerebral malaria. In: Shakir RA, Newman PK, Poser CM, eds. Tropical neurology. WB Saunders Company; 1996. p. 213-45.
79. Saissy JM. Le paludisme grave. In : Saissy JM, éd. Réanimation tropicale. Paris : Arnette ; 1997. p. 95-118.
80. Appit «Paludisme». In : Appit. Pilly E, éd. Montmorency : 2M2 ; 1997. p. 399-406.
81. Roué R, Debord T. L'accès pernicieux palustre. Rev Prat 1988; 38, 18 : 1168-72.
82. Clain J, Peytavin G, Gachot B, et al. Du bon usage thérapeutique de la quinine dans l'accès palustre à Plasmodium falciparum contracté en Afrique. Bull Soc Pathol Exot 1997 ; 90 : 260-2.
83. Charmot G, Le Bras J, Ringwald P, Coulaud JP. Les bases du traitement du paludisme à Plasmodium falciparum chimiorésistant en 1990. In : Vachon F, Coulaud JP, Pocidalo JJ, Vilde JL, éd. Chimiothérapie des parasitoses sévères en 1990. Paris : Arnette ; 1990. p. 29-38.
84. Gachot B, Houze S, Le Bras J, et al. Possible prognostic significance of a brief rise in parasitaemia following quinine treatment of severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1996 ; 90 : 388-90.
85. Bethell DB, Pham Tung Phuong, Cao Xuan Thanh Phuong, et al. Electrocardiographic monitoring in severe falciparum malaria. Trans R Soc Trop Med Hyg 1996 ; 90 : 266-9.
86. Kremsner PG, Radloff P, Metzger W, et al. Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother 1995 ; 39 : 1603-5.
87. Hien TT, Day NPJ, Phu NH, Mai NTH, Chau TTH, Loc PP, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996 ; 335 : 76-83.
88. Boele Van Hensbroek M, Onyiorah E, Jaffar S, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996 ; 335 : 69-75.
89. Vachon F. Paludisme. Pour la pratique. Rev Prat 1998 ; 48 : 296-7.
90. Hoffman SL. Artemether in severe malaria - still too many deaths. N Engl J Med 1996 ; 335 : 124-5.